世界の静脈性潰瘍用治療市場予測 2023年-2029年

【英語タイトル】Global Venous Ulcer Treatment Market Growth 2023-2029

LP Informationが出版した調査資料(LP23DC08195)・商品コード:LP23DC08195
・発行会社(調査会社):LP Information
・発行日:2023年11月
・ページ数:107
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後2-3営業日)
・調査対象地域:グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野:医療機器&消耗品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,660 ⇒換算¥556,320見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,490 ⇒換算¥834,480見積依頼/購入/質問フォーム
Corporate User(閲覧人数制限なし)USD7,320 ⇒換算¥1,112,640見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界の静脈性潰瘍用治療市場」は、過去の販売実績から2022年の世界の静脈性潰瘍用治療の総販売量を検討し、2023年から2029年の予測される静脈性潰瘍用治療の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の静脈性潰瘍用治療の市場規模を掲載し、XXX百万米ドル規模の世界の静脈性潰瘍用治療市場の詳細な分析を提供します。本インサイトレポートは、世界の静脈性潰瘍用治療業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の静脈性潰瘍用治療市場における各社の独自のポジションをより深く理解するために、静脈性潰瘍用治療製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の静脈性潰瘍用治療市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。静脈性潰瘍用治療の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000%と予測されています。静脈性潰瘍用治療の中国市場は、2023年から2029年までの年平均000%成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。静脈性潰瘍用治療のヨーロッパ市場は、2023年から2029年にかけて年平均000%成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

静脈性潰瘍用治療の世界主要メーカーとしては、Angiodynamics、 Bayer AG、 Sanofi S.A、 Pfizer Inc.、 Activa Healthcare、 Sigvaris Global、 Novo Nordisk、 Medtronic Plc.、 Alfa Wassermann SpA、 LDO、 Gloria、 Leawell International Limitedなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000%のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の静脈性潰瘍用治療市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査では静脈性潰瘍用治療市場をセグメンテーションし、種類別 (外科的治療、内科的治療)、用途別 (病院、診療所、家庭)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分:外科的治療、内科的治療

・用途別区分:病院、診療所、家庭

・地域別区分
南北アメリカ(アメリカ、カナダ、メキシコ、ブラジル)
アジア太平洋(中国、日本、韓国、東南アジア、インド、オーストラリア)
ヨーロッパ(ドイツ、フランス、イギリス、イタリア、ロシア)
中東・アフリカ(エジプト、南アフリカ、イスラエル、トルコ、GCC諸国)

【本レポートで扱う主な質問】

・世界の静脈性潰瘍用治療市場の10年間の市場状況・展望は?
・世界および地域別に見た静脈性潰瘍用治療市場成長の要因は何か?
・静脈性潰瘍用治療の市場機会はエンドマーケットの規模によってどのように変化するのか?
・静脈性潰瘍用治療のタイプ別、用途別の内訳は?
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は?

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要:静脈性潰瘍用治療の年間販売量2018-2029、地域別現状・将来分析
・静脈性潰瘍用治療の種類別セグメント:外科的治療、内科的治療
・静脈性潰瘍用治療の種類別販売量:2018-2023年の販売量、売上、市場シェア、販売価格
・静脈性潰瘍用治療の用途別セグメント:病院、診療所、家庭
・静脈性潰瘍用治療の用途別販売量:2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の静脈性潰瘍用治療市場
・企業別のグローバル静脈性潰瘍用治療市場データ:2018-2023年の年間販売量、市場シェア
・企業別の静脈性潰瘍用治療の年間売上:2018-2023年の売上、市場シェア
・企業別の静脈性潰瘍用治療販売価格
・主要企業の静脈性潰瘍用治療生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

静脈性潰瘍用治療の地域別レビュー
・地域別の静脈性潰瘍用治療市場規模2018-2023:年間販売量、売上
・主要国別の静脈性潰瘍用治療市場規模2018-2023:年間販売量、売上
・南北アメリカの静脈性潰瘍用治療販売の成長
・アジア太平洋の静脈性潰瘍用治療販売の成長
・ヨーロッパの静脈性潰瘍用治療販売の成長
・中東・アフリカの静脈性潰瘍用治療販売の成長

南北アメリカ市場
・南北アメリカの国別の静脈性潰瘍用治療販売量、売上(2018-2023)
・南北アメリカの静脈性潰瘍用治療の種類別販売量
・南北アメリカの静脈性潰瘍用治療の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の静脈性潰瘍用治療販売量、売上(2018-2023)
・アジア太平洋の静脈性潰瘍用治療の種類別販売量
・アジア太平洋の静脈性潰瘍用治療の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の静脈性潰瘍用治療販売量、売上(2018-2023)
・ヨーロッパの静脈性潰瘍用治療の種類別販売量
・ヨーロッパの静脈性潰瘍用治療の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の静脈性潰瘍用治療販売量、売上(2018-2023)
・中東・アフリカの静脈性潰瘍用治療の種類別販売量
・中東・アフリカの静脈性潰瘍用治療の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・静脈性潰瘍用治療の製造コスト構造分析
・静脈性潰瘍用治療の製造プロセス分析
・静脈性潰瘍用治療の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル:直接販売チャンネル、間接販売チャンネル
・静脈性潰瘍用治療の主要なグローバル販売業者
・静脈性潰瘍用治療の主要なグローバル顧客

地域別の静脈性潰瘍用治療市場予測レビュー
・地域別の静脈性潰瘍用治療市場規模予測(2024-2029)
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・静脈性潰瘍用治療の種類別市場規模予測
・静脈性潰瘍用治療の用途別市場規模予測

主要企業分析
Angiodynamics、 Bayer AG、 Sanofi S.A、 Pfizer Inc.、 Activa Healthcare、 Sigvaris Global、 Novo Nordisk、 Medtronic Plc.、 Alfa Wassermann SpA、 LDO、 Gloria、 Leawell International Limited
・企業情報
・静脈性潰瘍用治療製品
・静脈性潰瘍用治療販売量、売上、価格、粗利益(2018-2023)
・主要ビジネス概要
・最新動向

調査結果および結論

The global Venous Ulcer Treatment market size is projected to grow from US$ 2775.3 million in 2022 to US$ 4206.3 million in 2029; it is expected to grow at a CAGR of 6.1% from 2023 to 2029.
United States market for Venous Ulcer Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Venous Ulcer Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Venous Ulcer Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Venous Ulcer Treatment players cover Angiodynamics, Bayer AG, Sanofi S.A, Pfizer Inc., Activa Healthcare, Sigvaris Global, Novo Nordisk, Medtronic Plc. and Alfa Wassermann SpA, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Venous ulcers are mainly caused by venous blood stasis in the lower extremities. Mostly caused by venous diseases, mainly including primary superficial venous insufficiency of the lower extremities, primary deep venous insufficiency of the lower extremities, deep and superficial communicating branch valvular insufficiency, post-thrombotic syndrome of the deep veins of the lower extremities, etc. This kind of ulcer mostly occurs on the inner or outer side of the lower 1/3 of the calf, and the inner side is more common, and it is often accompanied by swelling and pigmentation of the surrounding tissues. Sulodexide can be taken orally for venous ulcers.
LPI (LP Information)’ newest research report, the “Venous Ulcer Treatment Industry Forecast” looks at past sales and reviews total world Venous Ulcer Treatment sales in 2022, providing a comprehensive analysis by region and market sector of projected Venous Ulcer Treatment sales for 2023 through 2029. With Venous Ulcer Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Venous Ulcer Treatment industry.
This Insight Report provides a comprehensive analysis of the global Venous Ulcer Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Venous Ulcer Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Venous Ulcer Treatment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Venous Ulcer Treatment and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Venous Ulcer Treatment.
This report presents a comprehensive overview, market shares, and growth opportunities of Venous Ulcer Treatment market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Surgical Treatment
Medical Treatement
Segmentation by application
Hospital
Clinic
Home
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Angiodynamics
Bayer AG
Sanofi S.A
Pfizer Inc.
Activa Healthcare
Sigvaris Global
Novo Nordisk
Medtronic Plc.
Alfa Wassermann SpA
LDO
Gloria
Leawell International Limited
Key Questions Addressed in this Report
What is the 10-year outlook for the global Venous Ulcer Treatment market?
What factors are driving Venous Ulcer Treatment market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Venous Ulcer Treatment market opportunities vary by end market size?
How does Venous Ulcer Treatment break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Venous Ulcer Treatment Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Venous Ulcer Treatment by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Venous Ulcer Treatment by Country/Region, 2018, 2022 & 2029
2.2 Venous Ulcer Treatment Segment by Type
2.2.1 Surgical Treatment
2.2.2 Medical Treatement
2.3 Venous Ulcer Treatment Sales by Type
2.3.1 Global Venous Ulcer Treatment Sales Market Share by Type (2018-2023)
2.3.2 Global Venous Ulcer Treatment Revenue and Market Share by Type (2018-2023)
2.3.3 Global Venous Ulcer Treatment Sale Price by Type (2018-2023)
2.4 Venous Ulcer Treatment Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Home
2.5 Venous Ulcer Treatment Sales by Application
2.5.1 Global Venous Ulcer Treatment Sale Market Share by Application (2018-2023)
2.5.2 Global Venous Ulcer Treatment Revenue and Market Share by Application (2018-2023)
2.5.3 Global Venous Ulcer Treatment Sale Price by Application (2018-2023)
3 Global Venous Ulcer Treatment by Company
3.1 Global Venous Ulcer Treatment Breakdown Data by Company
3.1.1 Global Venous Ulcer Treatment Annual Sales by Company (2018-2023)
3.1.2 Global Venous Ulcer Treatment Sales Market Share by Company (2018-2023)
3.2 Global Venous Ulcer Treatment Annual Revenue by Company (2018-2023)
3.2.1 Global Venous Ulcer Treatment Revenue by Company (2018-2023)
3.2.2 Global Venous Ulcer Treatment Revenue Market Share by Company (2018-2023)
3.3 Global Venous Ulcer Treatment Sale Price by Company
3.4 Key Manufacturers Venous Ulcer Treatment Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Venous Ulcer Treatment Product Location Distribution
3.4.2 Players Venous Ulcer Treatment Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Venous Ulcer Treatment by Geographic Region
4.1 World Historic Venous Ulcer Treatment Market Size by Geographic Region (2018-2023)
4.1.1 Global Venous Ulcer Treatment Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Venous Ulcer Treatment Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Venous Ulcer Treatment Market Size by Country/Region (2018-2023)
4.2.1 Global Venous Ulcer Treatment Annual Sales by Country/Region (2018-2023)
4.2.2 Global Venous Ulcer Treatment Annual Revenue by Country/Region (2018-2023)
4.3 Americas Venous Ulcer Treatment Sales Growth
4.4 APAC Venous Ulcer Treatment Sales Growth
4.5 Europe Venous Ulcer Treatment Sales Growth
4.6 Middle East & Africa Venous Ulcer Treatment Sales Growth
5 Americas
5.1 Americas Venous Ulcer Treatment Sales by Country
5.1.1 Americas Venous Ulcer Treatment Sales by Country (2018-2023)
5.1.2 Americas Venous Ulcer Treatment Revenue by Country (2018-2023)
5.2 Americas Venous Ulcer Treatment Sales by Type
5.3 Americas Venous Ulcer Treatment Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Venous Ulcer Treatment Sales by Region
6.1.1 APAC Venous Ulcer Treatment Sales by Region (2018-2023)
6.1.2 APAC Venous Ulcer Treatment Revenue by Region (2018-2023)
6.2 APAC Venous Ulcer Treatment Sales by Type
6.3 APAC Venous Ulcer Treatment Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Venous Ulcer Treatment by Country
7.1.1 Europe Venous Ulcer Treatment Sales by Country (2018-2023)
7.1.2 Europe Venous Ulcer Treatment Revenue by Country (2018-2023)
7.2 Europe Venous Ulcer Treatment Sales by Type
7.3 Europe Venous Ulcer Treatment Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Venous Ulcer Treatment by Country
8.1.1 Middle East & Africa Venous Ulcer Treatment Sales by Country (2018-2023)
8.1.2 Middle East & Africa Venous Ulcer Treatment Revenue by Country (2018-2023)
8.2 Middle East & Africa Venous Ulcer Treatment Sales by Type
8.3 Middle East & Africa Venous Ulcer Treatment Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Venous Ulcer Treatment
10.3 Manufacturing Process Analysis of Venous Ulcer Treatment
10.4 Industry Chain Structure of Venous Ulcer Treatment
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Venous Ulcer Treatment Distributors
11.3 Venous Ulcer Treatment Customer
12 World Forecast Review for Venous Ulcer Treatment by Geographic Region
12.1 Global Venous Ulcer Treatment Market Size Forecast by Region
12.1.1 Global Venous Ulcer Treatment Forecast by Region (2024-2029)
12.1.2 Global Venous Ulcer Treatment Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Venous Ulcer Treatment Forecast by Type
12.7 Global Venous Ulcer Treatment Forecast by Application
13 Key Players Analysis
13.1 Angiodynamics
13.1.1 Angiodynamics Company Information
13.1.2 Angiodynamics Venous Ulcer Treatment Product Portfolios and Specifications
13.1.3 Angiodynamics Venous Ulcer Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Angiodynamics Main Business Overview
13.1.5 Angiodynamics Latest Developments
13.2 Bayer AG
13.2.1 Bayer AG Company Information
13.2.2 Bayer AG Venous Ulcer Treatment Product Portfolios and Specifications
13.2.3 Bayer AG Venous Ulcer Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Bayer AG Main Business Overview
13.2.5 Bayer AG Latest Developments
13.3 Sanofi S.A
13.3.1 Sanofi S.A Company Information
13.3.2 Sanofi S.A Venous Ulcer Treatment Product Portfolios and Specifications
13.3.3 Sanofi S.A Venous Ulcer Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Sanofi S.A Main Business Overview
13.3.5 Sanofi S.A Latest Developments
13.4 Pfizer Inc.
13.4.1 Pfizer Inc. Company Information
13.4.2 Pfizer Inc. Venous Ulcer Treatment Product Portfolios and Specifications
13.4.3 Pfizer Inc. Venous Ulcer Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Pfizer Inc. Main Business Overview
13.4.5 Pfizer Inc. Latest Developments
13.5 Activa Healthcare
13.5.1 Activa Healthcare Company Information
13.5.2 Activa Healthcare Venous Ulcer Treatment Product Portfolios and Specifications
13.5.3 Activa Healthcare Venous Ulcer Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Activa Healthcare Main Business Overview
13.5.5 Activa Healthcare Latest Developments
13.6 Sigvaris Global
13.6.1 Sigvaris Global Company Information
13.6.2 Sigvaris Global Venous Ulcer Treatment Product Portfolios and Specifications
13.6.3 Sigvaris Global Venous Ulcer Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Sigvaris Global Main Business Overview
13.6.5 Sigvaris Global Latest Developments
13.7 Novo Nordisk
13.7.1 Novo Nordisk Company Information
13.7.2 Novo Nordisk Venous Ulcer Treatment Product Portfolios and Specifications
13.7.3 Novo Nordisk Venous Ulcer Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Novo Nordisk Main Business Overview
13.7.5 Novo Nordisk Latest Developments
13.8 Medtronic Plc.
13.8.1 Medtronic Plc. Company Information
13.8.2 Medtronic Plc. Venous Ulcer Treatment Product Portfolios and Specifications
13.8.3 Medtronic Plc. Venous Ulcer Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Medtronic Plc. Main Business Overview
13.8.5 Medtronic Plc. Latest Developments
13.9 Alfa Wassermann SpA
13.9.1 Alfa Wassermann SpA Company Information
13.9.2 Alfa Wassermann SpA Venous Ulcer Treatment Product Portfolios and Specifications
13.9.3 Alfa Wassermann SpA Venous Ulcer Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Alfa Wassermann SpA Main Business Overview
13.9.5 Alfa Wassermann SpA Latest Developments
13.10 LDO
13.10.1 LDO Company Information
13.10.2 LDO Venous Ulcer Treatment Product Portfolios and Specifications
13.10.3 LDO Venous Ulcer Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 LDO Main Business Overview
13.10.5 LDO Latest Developments
13.11 Gloria
13.11.1 Gloria Company Information
13.11.2 Gloria Venous Ulcer Treatment Product Portfolios and Specifications
13.11.3 Gloria Venous Ulcer Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Gloria Main Business Overview
13.11.5 Gloria Latest Developments
13.12 Leawell International Limited
13.12.1 Leawell International Limited Company Information
13.12.2 Leawell International Limited Venous Ulcer Treatment Product Portfolios and Specifications
13.12.3 Leawell International Limited Venous Ulcer Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Leawell International Limited Main Business Overview
13.12.5 Leawell International Limited Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Venous Ulcer Treatment Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Venous Ulcer Treatment Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Surgical Treatment
Table 4. Major Players of Medical Treatement
Table 5. Global Venous Ulcer Treatment Sales by Type (2018-2023) & (K Units)
Table 6. Global Venous Ulcer Treatment Sales Market Share by Type (2018-2023)
Table 7. Global Venous Ulcer Treatment Revenue by Type (2018-2023) & ($ million)
Table 8. Global Venous Ulcer Treatment Revenue Market Share by Type (2018-2023)
Table 9. Global Venous Ulcer Treatment Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Venous Ulcer Treatment Sales by Application (2018-2023) & (K Units)
Table 11. Global Venous Ulcer Treatment Sales Market Share by Application (2018-2023)
Table 12. Global Venous Ulcer Treatment Revenue by Application (2018-2023)
Table 13. Global Venous Ulcer Treatment Revenue Market Share by Application (2018-2023)
Table 14. Global Venous Ulcer Treatment Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Venous Ulcer Treatment Sales by Company (2018-2023) & (K Units)
Table 16. Global Venous Ulcer Treatment Sales Market Share by Company (2018-2023)
Table 17. Global Venous Ulcer Treatment Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Venous Ulcer Treatment Revenue Market Share by Company (2018-2023)
Table 19. Global Venous Ulcer Treatment Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Venous Ulcer Treatment Producing Area Distribution and Sales Area
Table 21. Players Venous Ulcer Treatment Products Offered
Table 22. Venous Ulcer Treatment Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Venous Ulcer Treatment Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Venous Ulcer Treatment Sales Market Share Geographic Region (2018-2023)
Table 27. Global Venous Ulcer Treatment Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Venous Ulcer Treatment Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Venous Ulcer Treatment Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Venous Ulcer Treatment Sales Market Share by Country/Region (2018-2023)
Table 31. Global Venous Ulcer Treatment Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Venous Ulcer Treatment Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Venous Ulcer Treatment Sales by Country (2018-2023) & (K Units)
Table 34. Americas Venous Ulcer Treatment Sales Market Share by Country (2018-2023)
Table 35. Americas Venous Ulcer Treatment Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Venous Ulcer Treatment Revenue Market Share by Country (2018-2023)
Table 37. Americas Venous Ulcer Treatment Sales by Type (2018-2023) & (K Units)
Table 38. Americas Venous Ulcer Treatment Sales by Application (2018-2023) & (K Units)
Table 39. APAC Venous Ulcer Treatment Sales by Region (2018-2023) & (K Units)
Table 40. APAC Venous Ulcer Treatment Sales Market Share by Region (2018-2023)
Table 41. APAC Venous Ulcer Treatment Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Venous Ulcer Treatment Revenue Market Share by Region (2018-2023)
Table 43. APAC Venous Ulcer Treatment Sales by Type (2018-2023) & (K Units)
Table 44. APAC Venous Ulcer Treatment Sales by Application (2018-2023) & (K Units)
Table 45. Europe Venous Ulcer Treatment Sales by Country (2018-2023) & (K Units)
Table 46. Europe Venous Ulcer Treatment Sales Market Share by Country (2018-2023)
Table 47. Europe Venous Ulcer Treatment Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Venous Ulcer Treatment Revenue Market Share by Country (2018-2023)
Table 49. Europe Venous Ulcer Treatment Sales by Type (2018-2023) & (K Units)
Table 50. Europe Venous Ulcer Treatment Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Venous Ulcer Treatment Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Venous Ulcer Treatment Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Venous Ulcer Treatment Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Venous Ulcer Treatment Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Venous Ulcer Treatment Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Venous Ulcer Treatment Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Venous Ulcer Treatment
Table 58. Key Market Challenges & Risks of Venous Ulcer Treatment
Table 59. Key Industry Trends of Venous Ulcer Treatment
Table 60. Venous Ulcer Treatment Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Venous Ulcer Treatment Distributors List
Table 63. Venous Ulcer Treatment Customer List
Table 64. Global Venous Ulcer Treatment Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Venous Ulcer Treatment Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Venous Ulcer Treatment Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Venous Ulcer Treatment Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Venous Ulcer Treatment Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Venous Ulcer Treatment Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Venous Ulcer Treatment Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Venous Ulcer Treatment Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Venous Ulcer Treatment Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Venous Ulcer Treatment Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Venous Ulcer Treatment Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Venous Ulcer Treatment Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Venous Ulcer Treatment Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Venous Ulcer Treatment Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Angiodynamics Basic Information, Venous Ulcer Treatment Manufacturing Base, Sales Area and Its Competitors
Table 79. Angiodynamics Venous Ulcer Treatment Product Portfolios and Specifications
Table 80. Angiodynamics Venous Ulcer Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Angiodynamics Main Business
Table 82. Angiodynamics Latest Developments
Table 83. Bayer AG Basic Information, Venous Ulcer Treatment Manufacturing Base, Sales Area and Its Competitors
Table 84. Bayer AG Venous Ulcer Treatment Product Portfolios and Specifications
Table 85. Bayer AG Venous Ulcer Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Bayer AG Main Business
Table 87. Bayer AG Latest Developments
Table 88. Sanofi S.A Basic Information, Venous Ulcer Treatment Manufacturing Base, Sales Area and Its Competitors
Table 89. Sanofi S.A Venous Ulcer Treatment Product Portfolios and Specifications
Table 90. Sanofi S.A Venous Ulcer Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Sanofi S.A Main Business
Table 92. Sanofi S.A Latest Developments
Table 93. Pfizer Inc. Basic Information, Venous Ulcer Treatment Manufacturing Base, Sales Area and Its Competitors
Table 94. Pfizer Inc. Venous Ulcer Treatment Product Portfolios and Specifications
Table 95. Pfizer Inc. Venous Ulcer Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Pfizer Inc. Main Business
Table 97. Pfizer Inc. Latest Developments
Table 98. Activa Healthcare Basic Information, Venous Ulcer Treatment Manufacturing Base, Sales Area and Its Competitors
Table 99. Activa Healthcare Venous Ulcer Treatment Product Portfolios and Specifications
Table 100. Activa Healthcare Venous Ulcer Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Activa Healthcare Main Business
Table 102. Activa Healthcare Latest Developments
Table 103. Sigvaris Global Basic Information, Venous Ulcer Treatment Manufacturing Base, Sales Area and Its Competitors
Table 104. Sigvaris Global Venous Ulcer Treatment Product Portfolios and Specifications
Table 105. Sigvaris Global Venous Ulcer Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Sigvaris Global Main Business
Table 107. Sigvaris Global Latest Developments
Table 108. Novo Nordisk Basic Information, Venous Ulcer Treatment Manufacturing Base, Sales Area and Its Competitors
Table 109. Novo Nordisk Venous Ulcer Treatment Product Portfolios and Specifications
Table 110. Novo Nordisk Venous Ulcer Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Novo Nordisk Main Business
Table 112. Novo Nordisk Latest Developments
Table 113. Medtronic Plc. Basic Information, Venous Ulcer Treatment Manufacturing Base, Sales Area and Its Competitors
Table 114. Medtronic Plc. Venous Ulcer Treatment Product Portfolios and Specifications
Table 115. Medtronic Plc. Venous Ulcer Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Medtronic Plc. Main Business
Table 117. Medtronic Plc. Latest Developments
Table 118. Alfa Wassermann SpA Basic Information, Venous Ulcer Treatment Manufacturing Base, Sales Area and Its Competitors
Table 119. Alfa Wassermann SpA Venous Ulcer Treatment Product Portfolios and Specifications
Table 120. Alfa Wassermann SpA Venous Ulcer Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Alfa Wassermann SpA Main Business
Table 122. Alfa Wassermann SpA Latest Developments
Table 123. LDO Basic Information, Venous Ulcer Treatment Manufacturing Base, Sales Area and Its Competitors
Table 124. LDO Venous Ulcer Treatment Product Portfolios and Specifications
Table 125. LDO Venous Ulcer Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. LDO Main Business
Table 127. LDO Latest Developments
Table 128. Gloria Basic Information, Venous Ulcer Treatment Manufacturing Base, Sales Area and Its Competitors
Table 129. Gloria Venous Ulcer Treatment Product Portfolios and Specifications
Table 130. Gloria Venous Ulcer Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. Gloria Main Business
Table 132. Gloria Latest Developments
Table 133. Leawell International Limited Basic Information, Venous Ulcer Treatment Manufacturing Base, Sales Area and Its Competitors
Table 134. Leawell International Limited Venous Ulcer Treatment Product Portfolios and Specifications
Table 135. Leawell International Limited Venous Ulcer Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. Leawell International Limited Main Business
Table 137. Leawell International Limited Latest Developments
List of Figures
Figure 1. Picture of Venous Ulcer Treatment
Figure 2. Venous Ulcer Treatment Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Venous Ulcer Treatment Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Venous Ulcer Treatment Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Venous Ulcer Treatment Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Surgical Treatment
Figure 10. Product Picture of Medical Treatement
Figure 11. Global Venous Ulcer Treatment Sales Market Share by Type in 2022
Figure 12. Global Venous Ulcer Treatment Revenue Market Share by Type (2018-2023)
Figure 13. Venous Ulcer Treatment Consumed in Hospital
Figure 14. Global Venous Ulcer Treatment Market: Hospital (2018-2023) & (K Units)
Figure 15. Venous Ulcer Treatment Consumed in Clinic
Figure 16. Global Venous Ulcer Treatment Market: Clinic (2018-2023) & (K Units)
Figure 17. Venous Ulcer Treatment Consumed in Home
Figure 18. Global Venous Ulcer Treatment Market: Home (2018-2023) & (K Units)
Figure 19. Global Venous Ulcer Treatment Sales Market Share by Application (2022)
Figure 20. Global Venous Ulcer Treatment Revenue Market Share by Application in 2022
Figure 21. Venous Ulcer Treatment Sales Market by Company in 2022 (K Units)
Figure 22. Global Venous Ulcer Treatment Sales Market Share by Company in 2022
Figure 23. Venous Ulcer Treatment Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Venous Ulcer Treatment Revenue Market Share by Company in 2022
Figure 25. Global Venous Ulcer Treatment Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Venous Ulcer Treatment Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Venous Ulcer Treatment Sales 2018-2023 (K Units)
Figure 28. Americas Venous Ulcer Treatment Revenue 2018-2023 ($ Millions)
Figure 29. APAC Venous Ulcer Treatment Sales 2018-2023 (K Units)
Figure 30. APAC Venous Ulcer Treatment Revenue 2018-2023 ($ Millions)
Figure 31. Europe Venous Ulcer Treatment Sales 2018-2023 (K Units)
Figure 32. Europe Venous Ulcer Treatment Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Venous Ulcer Treatment Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Venous Ulcer Treatment Revenue 2018-2023 ($ Millions)
Figure 35. Americas Venous Ulcer Treatment Sales Market Share by Country in 2022
Figure 36. Americas Venous Ulcer Treatment Revenue Market Share by Country in 2022
Figure 37. Americas Venous Ulcer Treatment Sales Market Share by Type (2018-2023)
Figure 38. Americas Venous Ulcer Treatment Sales Market Share by Application (2018-2023)
Figure 39. United States Venous Ulcer Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Venous Ulcer Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Venous Ulcer Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Venous Ulcer Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Venous Ulcer Treatment Sales Market Share by Region in 2022
Figure 44. APAC Venous Ulcer Treatment Revenue Market Share by Regions in 2022
Figure 45. APAC Venous Ulcer Treatment Sales Market Share by Type (2018-2023)
Figure 46. APAC Venous Ulcer Treatment Sales Market Share by Application (2018-2023)
Figure 47. China Venous Ulcer Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Venous Ulcer Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Venous Ulcer Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Venous Ulcer Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Venous Ulcer Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Venous Ulcer Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Venous Ulcer Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Venous Ulcer Treatment Sales Market Share by Country in 2022
Figure 55. Europe Venous Ulcer Treatment Revenue Market Share by Country in 2022
Figure 56. Europe Venous Ulcer Treatment Sales Market Share by Type (2018-2023)
Figure 57. Europe Venous Ulcer Treatment Sales Market Share by Application (2018-2023)
Figure 58. Germany Venous Ulcer Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Venous Ulcer Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Venous Ulcer Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Venous Ulcer Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Venous Ulcer Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Venous Ulcer Treatment Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Venous Ulcer Treatment Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Venous Ulcer Treatment Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Venous Ulcer Treatment Sales Market Share by Application (2018-2023)
Figure 67. Egypt Venous Ulcer Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Venous Ulcer Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Venous Ulcer Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Venous Ulcer Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Venous Ulcer Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Venous Ulcer Treatment in 2022
Figure 73. Manufacturing Process Analysis of Venous Ulcer Treatment
Figure 74. Industry Chain Structure of Venous Ulcer Treatment
Figure 75. Channels of Distribution
Figure 76. Global Venous Ulcer Treatment Sales Market Forecast by Region (2024-2029)
Figure 77. Global Venous Ulcer Treatment Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Venous Ulcer Treatment Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Venous Ulcer Treatment Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Venous Ulcer Treatment Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Venous Ulcer Treatment Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界の静脈性潰瘍用治療市場予測 2023年-2029年] (コード:LP23DC08195)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の静脈性潰瘍用治療市場予測 2023年-2029年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆